Drug prices not justified by industry’s research and development spending
Most industry spending is not on research and development Government action needed to encourage research and development focused on public health priorities High drug prices are not justified by industry’s spending on research and development (R&D), argue experts in The BMJ today. Aris Angelis and colleagues point out that from ...